The largest database of trusted experimental protocols

Sunitinib l malate

Manufactured by Pfizer
Sourced in United States

Sunitinib L-malate is a multi-targeted receptor tyrosine kinase inhibitor. It is used as a laboratory research tool for the study of various cellular processes and signaling pathways.

Automatically generated - may contain errors

2 protocols using sunitinib l malate

1

Preparation of Sunitinib and PFK15 Solutions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stock solutions of the multikinase inhibitor Sunitinib L-malate (Pfizer, New York, NY, USA) (abbreviated to Sunitinib or SU in the text for simplification) and the glucose metabolism inhibitor (E)-1-(pyridin-4-yl)-3-(quinolin-2-yl)prop-2-en-1-one (PFK15) were prepared in dimethyl sulfoxide (DMSO; Sigma-Aldrich, USA) at a concentration of 10 mM. The stock solutions were subsequently diluted in an appropriate concentration in ECGM (and finally in test solutions containing 1% DMSO) for the in vitro experiments. Sunitinib was obtained as a gift from a pharmaceutical company (Pfizer Inc., New York, NY, USA). The synthesis and exact structure assignments of PFK15 were performed as described above.
+ Open protocol
+ Expand
2

Preparation of Tyrosine Kinase and Glucose Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stocks solutions of tyrosine kinase receptors inhibitor sunitinib l-malate (Pfizer, USA) and glucose metabolism inhibitor 3PO, synthetized as described in Murár et al. (2018) (link), were dissolved in dimethyl sulfoxide (DMSO; Sigma-Aldrich, USA) in a concentration of 10 mM. Subsequently, stock solutions were diluted in ECGM to required concentration. All inhibitors were used at concentration, which induced no cytotoxicity.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!